Activators of soluble guanylate cyclase for the treatment of male erectile dysfunction

International Journal of Impotence Research

Volumn 14, Issue 1, 2002, Pages 8-14

  Brioni, J D ^a   Nakane, M ^a   Hsieh, G C ^a   Moreland, R B ^a   Kolasa, T ^a   Sullivan, J P ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

cGMP; Corpus cavernosum; Erectile dysfunction; Guanylate cyclase; Penile erection; Sildenafil; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; APOMORPHINE; CYCLIC GMP; GLYCERYL TRINITRATE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; ISOLIQUIRITIGENIN; METHYLENE BLUE; MINOXIDIL; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; TADALAFIL;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING SITE; CORPUS CAVERNOSUM; DRUG BINDING; DRUG EFFICACY; DRUG STRUCTURE; ERECTILE DYSFUNCTION; HUMAN; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; STIMULATION;

ALLOSTERIC SITE; ANIMALS; ENZYME ACTIVATORS; GUANYLATE CYCLASE; HUMANS; IMPOTENCE; INDAZOLES; MALE; SOLUBILITY;

EID: 0036192244     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900801     Document Type: Article

References (55)

1. The biochemical and neurologic basis for the treatment of male erectile dysfunction
2. Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung
3. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung
4. A new form of guanylyl cyclase is preferentially expressed in rat kidney
5. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure
6. Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme
7. Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brain
8. Human soluble guanylate cyclase: Functional expression and revised isoenzyme family
9. The beta(2) subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma
10. Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: Synergism of nitric oxide and YC-1
11. Soluble guanylate cyclase from rat lung exists as a heterodimer
12. Guanylate cyclase and the NO/cGMP signaling pathway
13. Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method
14. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase
15. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase
16. Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite
17. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase
18. Inhibition of nitric oxide synthesis by methylene blue
19. LY-83583 stimulates glucose transporter-1-mediated glucose transport independent of changes in cGMP levels
20. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta
21. Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle
22. Cardiac effects of isoliquiritigenin
23. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase
24. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators
25. A molecular basis for nitric oxide sensing by soluble guanylate cyclase
26. Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation
27. Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: Acceleration by thiols and oxyhemoglobin
28. Regulation of enzyme activity
29. Allosteric proteins and cellular control systems
30. Mechanism of YC-1-induced activation of soluble guanylyl cyclase
31. NO-independent regulatory site on soluble guanylate cyclase
32. A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: Implications for the YC-1 binding site?
33. Molecular mechanism of cGMP-mediated smooth muscle relaxation
34. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity
35. YC-1 potentiates nitric oxide-induced relaxation in guinea-pig trachea
36. Efects of the nitric oxide synthase inhibitor N-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit
37. Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum
38. Acute effects of nitric oxide and cyclic GMP on human myocardial contractility
39. Guanylyl cyclases and signaling by cyclic GMP
40. Soluble guanylate cyclase: The forgotten sibling
41. Inhibition by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) of responses to nitric oxide-donors in rat pulmonary artery: Influence of the mechanism of nitric oxide generation
42. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation
43. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat
44. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells
45. YC-1 enhances the responsiveness of tolerant vascular smooth to glyceryl trinitrate
46. Physiology of penile erection
47. YC-1, a NO-independent guanylate cyclase stimulator, relaxes rabbit cavernous smooth muscle via increasing intracellular cyclic GMP
48. YC-1, a novel activator of platelet guanylate cyclase
49. YC-1, a nitric-oxide independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice
50. Acute blood pressure effects of YC-1 induce activation of guanylate cyclase in normotensive and hypertensive rats
51. Pathophysiology of erectile dysfunction: The contributions of trabecular structure to function and the role of functional antagonism
52. The epidemiology and pathophysiology of erectile dysfunction
53. Adenylate and guanylate cyclase activity in the penis and aorta of the diabetic rat: An in vitro study